Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-d-aspartate receptors by memantine-Reference-Cited by-同舟云学术

Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-d-aspartate receptors by memantine

Published:2007-09 Issue:3 Volume:53 Page:415-420
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Gilling K.E.,Jatzke C.,Parsons C.G.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference26 articles.

1. Results of a randomised, placebo-controlled 6-month study of memantine in the treatment of mild to moderate Alzheimer's disease in Europe;Bakchine,2005

2. Trapping channel block of NMDA-activated responses by amantadine and memantine;Blanpied;J. Neurophysiol.,1997

3. Memantine is a potent blocker of N-methyl-d-aspartate (NMDA) receptor channels;Bormann;Eur. J. Pharmacol.,1989

4. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells;Bresink;Br. J. Pharmacol.,1996

5. Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine—therapeutic advantage against NMDA receptor-mediated neurotoxicity;Chen;J. Neurosci.,1992

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Memantine: Updating a rare success story in pro-cognitive therapeutics;Neuropharmacology;2024-02

2. Effects of Mg2+ on recovery of NMDA receptors from inhibition by memantine and ketamine reveal properties of a second site;Neuropharmacology;2018-07

3. Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization;The Journal of Neuroscience;2017-09-06

4. Memantine and Kynurenic Acid: Current Neuropharmacological Aspects;Current Neuropharmacology;2016-02-15

5. Memantine Extended Release (28 mg Once Daily): A Review of Its Use in Alzheimer’s Disease;Drugs;2015-04-22